
doi: 10.1093/bjd/ljae511
pmid: 39724212
We report a patient with psoriasis vulgaris who developed tinea corporis at the injection site of ixekizumab, an IL-17 inhibitor. This case suggests that local inhibition of IL-17 may reduce dermatophyte resistance, leading to site-specific fungal infections.
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
